Return on average equity - 5 year average | 14.63 |
Net Income/employee - trailing 12 month | 48,40,638.00 |
Revenue/employee - most recent fiscal year | 1,00,03,250.00 |
Return on investment - most recent fiscal year | 25.46 |
Return on average assets - most recent fiscal year | 22.10 |
Receivables turnover - most recent fiscal year | 3.74 |
Return on investment - trailing 12 month | 30.85 |
Return on average assets - trailing 12 month | 26.82 |
Inventory turnover - most recent fiscal year | 1.08 |
Inventory turnover - trailing 12 month | 0.89 |
Revenue/employee - trailing 12 month | 1,13,56,080.00 |
Return on average assets - 5 year average | 12.33 |
Net Income/employee - most recent fiscal year | 34,72,921.00 |
Return on average equity - trailing 12 month | 31.26 |
Receivables turnover - trailing 12 month | 3.57 |
Asset turnover - most recent fiscal year | 0.64 |
Asset turnover - trailing 12 month | 0.63 |
Return on average equity - most recent fiscal year | 25.88 |
Return on investment - 5 year average | 14.25 |
Natco Pharma Dividend Natco Pharma Bonus Natco Pharma News Natco Pharma AGM Natco Pharma Rights Natco Pharma Splits Natco Pharma Board Meetings Natco Pharma Shareholdings Natco Pharma Profit Loss Natco Pharma Balance Sheet Natco Pharma Cashflow Natco Pharma Q1 Results Natco Pharma Q2 Results Natco Pharma Q3 Results Natco Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks